# Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

> **NCT02845531** · PHASE4 · RECRUITING · sponsor: **Kee-joon Choi** · enrollment: 140 (estimated)

## Conditions studied

- Angina Pectoris, Variant
- Sudden Cardiac Death

## Interventions

- **DEVICE:** Implantable Cardioverter Defibrillator
- **DRUG:** Optimal Medical Therapy

## Key facts

- **NCT ID:** NCT02845531
- **Lead sponsor:** Kee-joon Choi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-11-29
- **Primary completion:** 2030-12
- **Final completion:** 2031-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02845531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02845531, "Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02845531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*